Literature DB >> 25361592

Treating HSV and CMV reactivations in critically ill patients who are not immunocompromised: con.

G Chanques1, S Jaber.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25361592     DOI： 10.1007/s00134-014-3521-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  19 in total

Review 1.  Anemia in critical illness: insights into etiology, consequences, and management.

Authors:  Shailaja J Hayden; Tyler J Albert; Timothy R Watkins; Erik R Swenson
Journal:  Am J Respir Crit Care Med       Date:  2012-01-26       Impact factor: 21.405

2.  Lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1beta triggers reactivation of latent cytomegalovirus in immunocompetent mice.

Authors:  Charles H Cook; Joanne Trgovcich; Peter D Zimmerman; Yingxue Zhang; Daniel D Sedmak
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 3.  Hematologic complications of anti-CMV therapy in solid organ transplant recipients.

Authors:  Lara Danziger-Isakov; G Mark Baillie
Journal:  Clin Transplant       Date:  2008-12-18       Impact factor: 2.863

Review 4.  Recent developments in anti-herpesvirus drugs.

Authors:  Hugh J Field; R Anthony Vere Hodge
Journal:  Br Med Bull       Date:  2013-04-17       Impact factor: 4.291

5.  A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant.

Authors:  R A Bowden; S J Slichter; M Sayers; D Weisdorf; M Cays; G Schoch; M Banaji; R Haake; K Welk; L Fisher; J McCullough; W Miller
Journal:  Blood       Date:  1995-11-01       Impact factor: 22.113

6.  Pharmacology and clinical use of foscarnet.

Authors:  L Gérard; D Salmon-Céron
Journal:  Int J Antimicrob Agents       Date:  1995-07       Impact factor: 5.283

7.  Acyclovir-induced neuropsychosis successfully recovered after immediate hemodialysis in an end-stage renal disease patient.

Authors:  Hung-Hsu Yang; Yu-Ping Hsiao; Hung-Chun Shih; Jen-Hung Yang
Journal:  Int J Dermatol       Date:  2007-08       Impact factor: 2.736

Review 8.  A model for reactivation of CMV from latency.

Authors:  Mary Hummel; Michael M Abecassis
Journal:  J Clin Virol       Date:  2002-08       Impact factor: 3.168

9.  The seroepidemiology of herpes simplex virus type 1 and 2 in Europe.

Authors:  R G Pebody; N Andrews; D Brown; R Gopal; H De Melker; G François; N Gatcheva; W Hellenbrand; S Jokinen; I Klavs; M Kojouharova; T Kortbeek; B Kriz; K Prosenc; K Roubalova; P Teocharov; W Thierfelder; M Valle; P Van Damme; R Vranckx
Journal:  Sex Transm Infect       Date:  2004-06       Impact factor: 3.519

10.  Cytomegalovirus and herpes simplex virus effect on the prognosis of mechanically ventilated patients suspected to have ventilator-associated pneumonia.

Authors:  Yannael Coisel; Sabri Bousbia; Jean-Marie Forel; Sami Hraiech; Bernard Lascola; Antoine Roch; Christine Zandotti; Matthieu Million; Samir Jaber; Didier Raoult; Laurent Papazian
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240
View more
  9 in total

1.  Interferon-γ production by CMV-specific CD8+ T lymphocytes provides protection against cytomegalovirus reactivation in critically ill patients.

Authors:  Juan José Castón; Sara Cantisán; Francisco González-Gasca; Aurora Páez-Vega; Hasania Abdel-Hadi; Soledad Illescas; Gema Alonso; Julián Torre-Cisneros
Journal:  Intensive Care Med       Date:  2015-11-04       Impact factor: 17.440

Review 2.  Cytomegalovirus infection in immunocompetent critically ill adults: literature review.

Authors:  Awad Al-Omari; Fadi Aljamaan; Waleed Alhazzani; Samer Salih; Yaseen Arabi
Journal:  Ann Intensive Care       Date:  2016-11-03       Impact factor: 6.925

3.  Cytomegalovirus infection and outcome in immunocompetent patients in the intensive care unit: a systematic review and meta-analysis.

Authors:  Xi Li; Yongbo Huang; Zhiheng Xu; Rong Zhang; Xiaoqing Liu; Yimin Li; Pu Mao
Journal:  BMC Infect Dis       Date:  2018-06-28       Impact factor: 3.090

4.  Impact of acyclovir use on survival of patients with ventilator-associated pneumonia and high load herpes simplex virus replication.

Authors:  Lukas Schuierer; Michael Gebhard; Hans-Georg Ruf; Ulrich Jaschinski; Thomas M Berghaus; Michael Wittmann; Georg Braun; Dirk H Busch; Reinhard Hoffmann
Journal:  Crit Care       Date:  2020-01-10       Impact factor: 9.097

Review 5.  Update in Viral Infections in the Intensive Care Unit.

Authors:  Paraskevi C Fragkou; Charalampos D Moschopoulos; Emmanouil Karofylakis; Theodoros Kelesidis; Sotirios Tsiodras
Journal:  Front Med (Lausanne)       Date:  2021-02-23

6.  [Management of infectious complications associated with coronavirus infection in severe patients admitted to ICU].

Authors:  Ángel Estella; Pablo Vidal-Cortés; Alejandro Rodriguez; David Andaluz Ojeda; Ignacio Martin-Loeches; Emili Díaz; Borja Suberviola; María Pilar Gracia Arnillas; Mercedes Catalán González; Francisco Álvarez-Lerma; Paula Ramirez; Xavier Nuvials; Marcio Borges Sa; Rafael Zaragoza
Journal:  Med Intensiva (Engl Ed)       Date:  2021-04-30

7.  Cytomegalovirus reactivation and mortality in patients with acute respiratory distress syndrome.

Authors:  David S Y Ong; Cristian Spitoni; Peter M C Klein Klouwenberg; Frans M Verduyn Lunel; Jos F Frencken; Marcus J Schultz; Tom van der Poll; Jozef Kesecioglu; Marc J M Bonten; Olaf L Cremer
Journal:  Intensive Care Med       Date:  2015-09-28       Impact factor: 17.440

8.  The role of high load herpes simplex virus in patients with mechanical ventilation: a real hospital acquired viral lung infection needs antiviral therapy?

Authors:  Heyan Wang; Hangyong He
Journal:  Crit Care       Date:  2020-04-07       Impact factor: 9.097

9.  Effect of antiviral therapy on the outcomes of mechanically ventilated patients with herpes simplex virus detected in the respiratory tract: a systematic review and meta-analysis.

Authors:  Stefan Hagel; André Scherag; Lukas Schuierer; Reinhard Hoffmann; Charles-Edouard Luyt; Mathias W Pletz; Miriam Kesselmeier; Sebastian Weis
Journal:  Crit Care       Date:  2020-09-29       Impact factor: 9.097
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.